A randomised trial of therapy in advanced Hodgkin's disease

Not Applicable

Completed

• Conditions: Hodgkin's lymphoma; Cancer; Hodgkin's disease

• Registration Number: ISRCTN97144519
• Lead Sponsor: Cancer Research UK (CRUK) (UK)

Brief Summary

2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16314615 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20498402 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2001-07-01
• Study Completion: 2002-01-01
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 807

Inclusion Criteria

1. Histologically proven Hodgkin's Disease requiring systemic therapy (this may also include patients with Clinical Stage IA or IIA in the presence of adverse factors, eg bulky disease or more than three sites of involvement)
2. Patient fit and able to receive chemotherapy
3. Informed consent

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration